cash flow reconciliationreview2024-06-30
Operating, investing and financing flows differ from the reported change in cash by 3507594, beyond tolerance 1000000.
Revenue
$4.56M
Fiscal year ended 2026-03-31Net income
-$109.34M
Fiscal year ended 2026-03-31Total assets
$200.37M
Fiscal year ended 2026-03-31UPEXI, INC. (UPXI) reported revenue of $4.56M and net income of -$109.34M for the fiscal year ended 2026-03-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from UPEXI, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Finance Services.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.56M | $8.05M | $9.24M | $4.29M | $3.16M | $4.01M | $4.36M | $5.04M | $5.22M | $7.46M |
| Cost of revenue | $206.36K | $1.34M | $956.74K | $884.10K | $1.60M | $1.03M | $1.43M | $3.48M | $3.96M | $2.90M |
| Gross profit | $4.35M | $6.71M | $8.28M | $3.40M | $1.56M | $2.97M | $2.93M | $1.56M | $1.27M | $4.57M |
| Operating income | -$106.79M | -$175.36M | $69.16M | -$6.50M | -$3.59M | -$1.07M | -$1.34M | -$13.37M | -$5.04M | -$2.60M |
| Net income | -$109.34M | -$178.92M | $66.75M | -$6.93M | -$3.83M | -$1.30M | -$1.63M | Unavailable | -$4.12M | -$2.44M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 65.51M | shares 60.83M | shares 88.48M | Unavailable | shares 1.34M | shares 1.05M | shares 1.05M | Unavailable | shares 1.02M | shares 1.02M |
| Pretax income | -$109.34M | -$178.92M | $66.75M | -$6.93M | -$3.83M | -$1.30M | -$1.63M | -$13.87M | -$5.79M | -$3.64M |
| Income tax expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$3.00M | $1.50M | $694.81K |
| Diluted EPS | $-1.67 | Unavailable | $0.76 | Unavailable | $-2.87 | $-1.24 | $1.55 | Unavailable | $-4.03 | $-2.00 |
| Selling, general & administrative | $5.48M | $6.44M | $10.32M | $7.35M | $3.68M | $2.50M | $2.41M | $3.23M | $3.07M | $3.07M |
| General & administrative | $4.93M | $5.52M | $9.26M | $6.38M | $2.64M | $1.55M | $1.37M | $1.82M | $1.79M | $1.58M |
| Selling & marketing | $553.30K | $915.84K | $1.07M | $970.41K | $1.04M | $949.96K | $1.04M | $1.41M | $1.28M | $1.49M |
Balance
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total assets | $200.37M | $271.14M | $419.73M | $123.81M | $15.07M | $17.53M | $18.60M | $23.51M | $56.51M | $62.16M |
| Current assets | $121.80M | $171.25M | $220.34M | $56.78M | $3.97M | $6.11M | $6.79M | $11.42M | $16.84M | $22.58M |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $70.82M | $77.85M | $64.63M | $32.56M | $10.80M | $10.62M | $9.77M | $12.66M | $24.19M | $24.26M |
| Total equity incl. NCI | -$51.92M | $48.72M | $210.79M | $90.10M | $1.85M | $3.76M | $5.03M | $6.52M | $22.06M | $25.46M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $215.24K | $728.27K | $1.04M | $1.15M | $1.32M | $2.24M | $1.64M | $1.43M | $8.80M | $14.66M |
| Accounts receivable | $496.39K | $594.55K | $284.26K | $157.52K | $180.90K | $1.16M | $801.44K | $606.88K | $4.71M | $5.38M |
| Goodwill | $673.85K | $673.85K | $848.85K | $848.85K | $848.85K | $848.85K | $848.85K | $848.85K | $10.85M | $11.81M |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $288.72K | $665.84K | $2.18M | $1.04M | $1.41M | $1.00M | $575.24K | $481.65K | $2.12M | $3.02M |
Cash flow
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.78M | -$2.68M | -$9.78M | -$4.29M | -$778.71K | -$1.38M | -$1.97M | $2.72M | $783.54K | $187.57K |
| Capital expenditures | $11.72K | $17.45K | $14.83K | $189.76K | $30.59K | $0 | $167.41K | $269.51K | $182.60K | $185.78K |
| Investing cash flow | $7.88M | -$6.49M | -$30.34M | -$105.05M | -$80.59K | $0 | $5.84M | -$2.29M | -$182.60K | -$1.05M |
| Financing cash flow | -$1.24M | $8.55M | $39.39M | $112.08M | $683.34K | $0 | -$2.73M | $7.63K | -$943.30K | $907.83K |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | -$175.96K | -$1.38M | $1.13M | $3.94M | -$3.09M | -$3.02M |
| Stock-based compensation | $3.99M | $8.30M | $5.76M | $1.41M | $521.35K | $32.58K | $141.30K | $204.61K | $212.76K | $330.58K |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $107.48K | $153.58K | $155.09K | $41.20K | $217.71K | $239.75K | $259.10K | $1.04M | $857.38K | $841.71K |
Derived
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$4.79M | -$2.70M | -$9.80M | -$4.48M | -$809.30K | -$1.38M | -$2.14M | $2.45M | $600.94K | $1.79K |
| Gross margin | 95.5% | 83.3% | 89.6% | 79.4% | 49.3% | 74.3% | 67.3% | 31.0% | 24.3% | 61.2% |
| Operating margin | -2343.3% | -2177.9% | 748.5% | -151.7% | -113.5% | -26.8% | -30.6% | -265.2% | -96.5% | -34.9% |
| FCF margin | -105.1% | -33.5% | -106.0% | -104.4% | -25.6% | -34.6% | -49.2% | 48.6% | 11.5% | 0.0% |
| SBC / revenue | 87.5% | 103.1% | 62.3% | 32.9% | 16.5% | 0.8% | 3.2% | 4.1% | 4.1% | 4.4% |
| Current ratio | 1.72x | 2.20x | 3.41x | 1.74x | 0.37x | 0.58x | 0.69x | 0.90x | 0.70x | 0.93x |
| Revenue YoY growth | 44.2% | 101.0% | 112.1% | -14.9% | -39.5% | -46.3% | -47.4% | Unavailable | -76.1% | -72.1% |
| Net margin | -2399.4% | Unavailable | Unavailable | -161.5% | -121.2% | Unavailable | Unavailable | Unavailable | -78.9% | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.3% | 0.2% | 0.2% | 4.4% | 1.0% | 0.0% | 3.8% | 5.3% | 3.5% | 2.5% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | 0.0% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open UPXI in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-05-12View SEC filing
10-Q · Filed 2026-02-10View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-K · Filed 2025-09-24View SEC filing
10-Q · Filed 2025-05-16View SEC filing
10-Q · Filed 2025-02-14View SEC filing
Reconciliation checks needing review
5 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
cash flow reconciliationreview2024-03-31
Operating, investing and financing flows differ from the reported change in cash by 2747612, beyond tolerance 1000000.
cash flow reconciliationreview2023-12-31
Operating, investing and financing flows differ from the reported change in cash by 3065506, beyond tolerance 1000000.
cash flow reconciliationreview2023-09-30
Operating, investing and financing flows differ from the reported change in cash by 1718972, beyond tolerance 1000000.
cash flow reconciliationreview2023-06-30
Operating, investing and financing flows differ from the reported change in cash by 1436154, beyond tolerance 1000000.